Canguo Zhao

发表

Expression-Based In Silico Screening of Candidate Therapeutic Compounds for Lung Adenocarcinoma

Canguo Zhao, Hongying Liao, Xiaoqin Yang, 2011, PloS one.

Triptolide sensitizes human breast cancer cells to tumor necrosis factor‑α‑induced apoptosis by inhibiting activation of the nuclear factor‑κB pathway.

Wenli Shi, Canguo Zhao, Xiaoli Cheng, 2016, Molecular medicine reports.

Original Article Gambogic acid moderates cardiac responses to chronic hypoxia likely by acting on the proteasome and NF-κB pathway

Jinbao Liu, Xiaofen Li, Xuejun Wang, 2013 .

Gambogic acid moderates cardiac responses to chronic hypoxia likely by acting on the proteasome and NF-κB pathway.

Jinbao Liu, Xiaofen Li, Xuejun Wang, 2013, American journal of cardiovascular disease.

Gambogic acid suppresses pressure overload cardiac hypertrophy in rats.

Jinbao Liu, Xiaofen Li, Xuejun Wang, 2013, American journal of cardiovascular disease.

Physiological levels of ATP negatively regulate proteasome function

Q. Dou, Jinbao Liu, P. Zhou, 2010, Cell Research.

Gambogic acid is a tissue-specific proteasome inhibitor in vitro and in vivo.

Q. Dou, Jinbao Liu, P. Zhou, 2013, Cell reports.

The combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivo.

Jinbao Liu, Xiaofen Li, Hongbiao Huang, 2014, Toxicology letters.

Sanggenon C decreases tumor cell viability associated with proteasome inhibition.

Q. Dou, Jinbao Liu, P. Zhou, 2011, Frontiers in bioscience.

Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth

Ping Zhou, Wenbin Song, Li Xu, 2014, Oncotarget.

Gambogic acid enhances proteasome inhibitor-induced anticancer activity.

Di Chen, Q. Dou, Jinbao Liu, 2011, Cancer letters.

A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy

D. Zang, Q. Dou, Jinbao Liu, 2016, Oncogene.